Home » Products » Sotagliflozin 400mg Tablets | GMP Manufacturer & Supplier | Sinophare
Product Description
| Product Name | Sotagliflozin Tablets (Sotagliflozin 400mg Oral Tablets) |
| Specification | Each tablet contains: Sotagliflozin 400mg |
| Dosage Form | Oral Film-Coated Tablet (for oral administration) |
| Active Ingredient | Sotagliflozin |
| Pharmacological Class | Sodium-Glucose Cotransporter 1/2 (SGLT1/SGLT2) Dual Inhibitor (Antidiabetic Agent) |
| Route of Administration | Oral administration (swallowed whole with water; take at approximately the same time each day, with or without food). |
| Packaging | Blister pack (PVC-Alu) or HDPE bottle, typically 30 tablets per blister pack or bottle |
| Storage | Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze. |
| Shelf Life | 24 months (unopened) |
Product Overview
Sotagliflozin Tablets is an oral preparation containing Sotagliflozin 400mg per film-coated tablet. Sotagliflozin is a dual inhibitor of sodium-glucose cotransporter 1 (SGLT1) and sodium-glucose cotransporter 2 (SGLT2). It is used as an adjunct to insulin to improve glycemic control in adults with type 1 diabetes mellitus. The product is formulated as film-coated tablets for oral administration, providing a convenient and accurate dosing form for daily oral therapy.
